Current treatment for organophosphate poisoning typically includes administration of a muscarinic receptor antagonist such as atropine, which blocks many of the autonomic and central nervous system symptoms of organophosphate poisoning, an oxime such as 2-pralidoxime (2-PAM), which reacts with the inactivated AChE to restore enzyme activity, and an anticonvulsant such as a benzodiazepine to stop seizures (Newmark 2004; Rusyniak and Nañagas 2004). The gene discussed is ACHE; the disease is organophosphate poisoning.